Popular Articles

Damon Runyon Cancer Research Foundation Awards $2.7M To 7 Top Young Clinical Investigators
The Damon Runyon Cancer Research Foundation named 4 new Damon Runyon Clinical Investigators at its April 2009 Clinical Investigator Award Committee review. The recipients of this prestigious, three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation"s leading scientists and clinicians. Each will receive $450,000 to support the development of his cancer research program.

Is P90RSK A New Therapeutic Target For Liver Fibrosis?
Cirrhosis is a world wide, bad prognosis liver disease and characterized by excessive collagen deposition and liver function damage. In our previous work, p90RSK is observed significantly up-regulated in association with elevated collagen type I levels in rat liver fibrosis. But detail mechanism of this phenomenon is still unknown.
Oncology

Ameritas Group Offers Oral Cancer Screening

"Ameritas believes strongly in the importance of preventive care and oral wellness education," said Roxann Brennfoerder, vice president - group customer relations and operations. Using new technology along with conventional visual exams, this simple screening makes it easier for dentists to detect oral cancer sooner, allowing patients to seek treatment sooner. Early detection is one of the keys to successful treatment for patients with oral cancer. In fact, according to the American Cancer Society (oral cancer in the United States, 2008 estimates), when oral cancer is found in its earliest stages, the five-year survival rate exceeds 80 percent. Ameritas Group


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):